Medical Weight-Loss 7.5mg Programme
Advanced dosage within the clinician-led Medical Weight Loss Programme.
Prescription-based treatment • Medical assessment required
Dosage Overview
The 7.5mg dosage may be prescribed where clinically appropriate as part of continued treatment within the Medical Weight Loss Programme. This dosage level represents an advanced stage of prescription-based therapy, including Mounjaro, determined through medical assessment and ongoing evaluation of treatment response.
Supportive IV therapy is incorporated to assist with hydration, nutrient balance, and overall wellbeing throughout treatment. Dosage decisions are guided by individual tolerance, clinical suitability, and structured medical oversight.
How This Dosage Is Used
-
Prescribed based on clinical assessment and patient response
-
May represent progression from an initial dosage level
-
Determined by medical suitability and patient tolerance
-
Forms part of a structured, supervised treatment pathway
What’s Included
-
Prescription-based treatment including Mounjaro (as clinically indicated)
-
Supportive Weight-Loss Support IV infusion
-
Ongoing monitoring and dosage review
-
Access to clinician-guided adjustments
Choose your weight loss programme
Mounjaro 7.5 mg + Weight-Loss Support IV
3-Month Plan
R27,729
Clinician-led subscription programme combining prescription treatment with supportive IV therapy to maintain hydration, nutrient balance, and energy levels throughout the programme.
Four combined Mounjaro and Weight-Loss Support treatment is administered each month for three months.
Suitable for initiating treatment under medical supervision.
Weight-Loss Support IV Infusion
3-Month Plan
R6,900
This Weight-Loss Support IV infusion complements prescribed Mounjaro therapy by delivering essential vitamins, amino acids, and metabolic nutrients directly into the bloodstream to support hydration, nutrient balance, and energy levels throughout treatment.
Four IV infusions per month are delivered throughout each three-month phase of the programme.
Designed for initiating IV metabolic support under medical supervision.
One-time payment • Secure checkout • Subscription active for selected duration
Best Value Programme
9-Month Metabolic Transformation Programme
A complete, clinician-guided treatment pathway designed to support sustained weight loss through structured Mounjaro dose escalation and monthly IV metabolic support.
Programme Structure
Each month includes four combined Mounjaro + Weight-Loss Support IV treatments, delivered weekly.
Over the full program, patients receive 36 treatments across 9 months, progressing through the 2.5 mg, 5 mg, and 7.5 mg dosage phases under clinical supervision.
2.5 mg Initiation Phase
Months 1–3
Introduces Mounjaro at a lower dose to allow the body to adapt to treatment while beginning metabolic and appetite regulation under clinical supervision.
Months 4–6
5 mg Progression Phase
The dosage is increased to maintain treatment effectiveness and support continued metabolic response as the body adjusts to therapy.
Months 7–9
7.5 mg Advanced Phase
A further increase in dosage helps sustain therapeutic impact and supports ongoing weight-management progress during the later stage of the programme.
12 Treatments delivered during this phase
12 Treatments delivered during this phase
12 Treatments delivered during this phase
Each monthly session includes a Weight-Loss Support IV infusion to help maintain hydration, nutrient balance, and energy levels throughout treatment.